United Parks & Resorts reports after the close on August 6 with a genuinely mixed setup: short interest has been creeping higher all week, analysts just raised targets across the board, and the stock has spent the past month drifting lower despite the positive analyst tone.
The positioning story is the most active thread right now. Short interest has climbed to 10.6% of the free float — roughly 5.8 million shares — up 3% on the week and sitting near the top of its recent range after spending most of July between 5.9 million and 6.2 million shares. The week-on-week rebuild is modest but directionally clear. Borrow remains cheap at 0.65%, barely changed over 30 days, so the shorts aren't paying to stay in — there's no squeeze pressure from the cost side. Availability has tightened meaningfully this week, dropping to 65% from 80% a week ago, meaning the lending pool is getting used up faster than new supply is appearing. That's still in the normal-to-tight range rather than extreme territory, but the direction — availability falling while short interest rises — is worth watching into a print. The ORTEX short score has been locked near 74.9 for two weeks, a level that puts PRKS in roughly the bottom 3% of the universe on the short score rank, reflecting the combination of elevated SI, tightening availability, and a multi-week build.
The analyst community told a different story this week. Three firms raised price targets on August 5 alone — a day before the earnings event — with Citigroup moving to $49 (from $46), Guggenheim lifting to $54 (from $51), and Barclays pushing up to $41 (from $37). Goldman Sachs had already raised to $41 from $37 on July 27. The consensus mean sits at $47.30 against a $46.17 close, implying only thin upside on average — but the breadth of the August 5 moves suggests firms are marking up into the print rather than expressing genuine conviction. The divergence in targets is wide: Guggenheim's $54 bull case stands more than 30% above Barclays' $41, which itself sits below the current price. On valuation, the stock trades at 9.7x trailing earnings and 7.3x EV/EBITDA, a modest discount to broader leisure peers. The EPS momentum factor scores well — 77th percentile on 90-day earnings momentum — but the EPS surprise rank of 39 suggests the company hasn't been a consistent beat-and-raise name. The only prior earnings reaction in the dataset, from the June 2026 quarter, was a -0.8% move the following day, recovering to near flat over five sessions.
The ownership picture has one notable feature: Hill Path Capital holds a dominant 57.7% of shares, a concentration that effectively limits free float and amplifies short interest dynamics. With Hill Path's stake stable and a number of smaller activist-leaning funds — Long Pond, Voss Capital, Engine Capital — all holding meaningful positions, the remaining float is thinly traded. That concentration is part of why a 10.6% SI reading against the float carries more weight here than it might elsewhere.
Options positioning is marginally more defensive than the recent norm. The put/call ratio reached 0.0197 on August 4, about 1.7 standard deviations above its 20-day average of 0.012 — not extreme, but the highest reading in roughly six weeks. The absolute PCR level remains low in isolation; the context is a stock that has historically seen very little put demand.
The key question heading into Thursday's print is whether the company can arrest the attendance softness that bears have flagged and justify the target lifts analysts just filed. The gap between Guggenheim's $54 and Barclays' $41 tells you the Street has not reached a view.
See the live data behind this article on ORTEX.
Open PRKS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
